GPX4 and malignant glioma: While GPX4 inhibition via RSL3 led to a non-significant survival benefit in a murine MG3 tumor model, a significant survival benefit was seen when GPX4 inhibition was combined with cysteine and methionine restriction, suggesting a future role for ferroptotic agents may exist in the treatment of malignant gliomas [134].